Bayer Pharma invests in HTGF II

Pharmaceutical companies could now be a new focus for the fund, which specialises in providing financing, networks and contacts to German start-ups in the life sciences sectors.

Bayer Pharma is the 20th investor in HTGF's second fund, which now totals €304m. According to unquote" data, the fund held its second close on €301.5m in January 2013.

Around €41.5m of the fund was raised from 17 private investors, including BASF, Deutsche Telekom and Tengelmann. The German Federal Ministry for Economic Affairs and Enery is the fund's cornerstone investor, having commited €220m, while the KfW banking group has provided a further €40m.

HTGF II backed three companies in March 2014: second-hand designer fashion website Rebelle received approximately €2m from HTGF in a €5m series-A funding round; Munich-based MicroDimensions, a company specialising in microscopic image processing, was the recipient of growth capital; while wheelchair seating system developer Desino received €500,000 in seed funding.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Germany